EUVIMEDEUVIMED entdecken
Open Access

Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes

Teresa K Chen, Steven G Coca, Heather R Thiessen-Philbrook, Hiddo J L Heerspink, Wassim Obeid, Joachim H Ix, Linda F Fried, Joseph V Bonventre, Joe M El-Khoury, Michael G Shlipak, Chirag R Parikh, CKD Biomarkers Consortium (BioCon)

American Journal of Nephrology · 2022

DOI: 10.1159/000528918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Nephrology, 2022. Verfasst von Teresa K Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Health Research Collaborative and Department of Medicine, University of California, San Francisco, California and San Francisco VA Health Care…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Diabetes Mellitus, Kidney Failure, Chronic. Die Arbeit wurde bisher 18-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetes is a leading cause of end-stage kidney disease (ESKD). Biomarkers of tubular health may prognosticate chronic kidney disease (CKD) progression beyond estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR).

Methods

We examined associations of five urinary biomarkers of tubular injury and repair (NGAL, KIM-1, IL-18, MCP-1, YKL-40) with kidney function decline (first occurrence of a decrease in eGFR ≥30 mL/min/1.73 m2 if randomization eGFR ≥60 or ≥50% if randomization eGFR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicDiabetes MellitusKidney Failure, ChronicHumansAgedInterleukin-18Chitinase-3-Like Protein 1Lipocalin-2BiomarkersGlomerular Filtration RateKidney

Stichwörter der Autor:innen

Diabetic kidney diseaseIL-18KIM-1MCP-1MortalityNGALYKL-40

Substanzen

Interleukin-18Chitinase-3-Like Protein 1Lipocalin-2Biomarkers

Autor:innen und Institutionen

  • Kidney Health Research Collaborative and Department of Medicine, University of California, San Francisco, California and San Francisco VA Health Care System, San Francisco, California, USA.
  • Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • The George Institute for Global Health, Sydney, New South Wales, Australia.
  • Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, And Veterans Affairs San Diego Healthcare System, San Diego, California, USA.
  • Renal Section, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Chen, T. K., Coca, S. G., Thiessen-Philbrook, H. R., Heerspink, H. J. L., Obeid, W., Ix, J. H., Fried, L. F., Bonventre, J. V., El-Khoury, J. M., Shlipak, M. G., Parikh, C. R., & CKD Biomarkers Consortium (BioCon) (2022). Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes. American Journal of Nephrology. https://doi.org/10.1159/000528918

Vancouver

Chen TK, Coca SG, Thiessen-Philbrook HR, Heerspink HJL, Obeid W, Ix JH, et al. Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes. American Journal of Nephrology. 2022. doi:10.1159/000528918

BibTeX
@article{Chen2022,
  author = {Chen, Teresa K and Coca, Steven G and Thiessen-Philbrook, Heather R and Heerspink, Hiddo J L and Obeid, Wassim and Ix, Joachim H and Fried, Linda F and Bonventre, Joseph V and El-Khoury, Joe M and Shlipak, Michael G and Parikh, Chirag R and CKD Biomarkers Consortium (BioCon), CKD Biomarkers Consortium (BioCon)},
  title = {Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes},
  journal = {American Journal of Nephrology},
  year = {2022},
  doi = {10.1159/000528918}
}
Kostenlos starten →